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Renaming non-
communicable diseases
The call  by Luke Allen and 
Andrea Feigl (February, 2017)1 to 
reframe non-communicable diseases 
(NCDs) is welcome. The lack of focus 
on these increasingly important 
causes of morbidity, impairment, and 
mortality, with their commensurate 
i n c r e a s i n g  c o n s u m p t i o n  o f 
health and societal resources and 
reduced economic contribution, is 
inappropriate and damaging for all 
the reasons Allen and Feigl cogently 
argue. Few things that are described 
in the negative as what they are not 
obtain the understanding or action 
they deserve. Would we call for 
more non-lay people and non-retail 
products to address the non-static 
numbers of persons with non-normal 
mobility and physiology?
However, moving from what not to 
call NCDs to what better to call them 
requires a considered and constructive 
approach. The objectives at a system 
level are to achieve better under-
standing of the conditions, their 
personal and societal impact, and 
the health and care actions needed, 
especially as numbers increase 
inexorably owing to medical advances 
and the ageing demo graphic. More 
importantly, at a personal level, any 
new term needs to resonate with and 
represent patients and their carers. 
The term needs to be credible, and 
indeed compelling, to policy makers, 
politicians, and donors in particular. It 
needs to be applicable in high-income 
as well as low-income countries, and 
in all health systems. Conceptual, 
academic, or high-level terms are 
therefore unlikely to succeed.
There may also be an age issue. 
Conditions affecting mature adults 
and older people will be perceived as 
something broadly correlating with 
the ageing process, and its variation in 
individuals. But for children and young 
adults, a term that smacks of the onset 
of elderliness while still in youth with 
be demoralising and a disincentive 
to seeking to optimise function and 
performance.
A suitable generic term might 
therefore be life-long disease (LLD). 
This does not imply poor prognosis, or 
indeed any lack of hope of remission, 
but almost all such diseases even if 
controlled or in remission will still need 
monitoring or check-ups, with their 
resource and lifestyle implica tions. 
This term does indicate an increasing 
occurrence in an ageing society. 
However, for younger people, a variant 
of learn-to-live-with conditions, made 
vernacularly attractive as L2Ls, would 
indicate a long-term situation but with 
a positive process of understanding 
and planning of lifestyle and health 
throughout a normal lifespan.
For policy makers, health planners, 
donors, and epidemiologists, LLDs 
and L2Ls would be clear terms and 
the resource requirements, as well 
as societal understanding, would be 
seen as necessary to be supportive. 
Above all, the terms would be equally 
meaningful to all citizens as well as to 
global institutions, and are devoid of 
any stigma.
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